LYMPHOCYTIC LEUKEMIA, CHRONIC
Clinical trials for LYMPHOCYTIC LEUKEMIA, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOCYTIC LEUKEMIA, CHRONIC trials appear
Sign up with your email to follow new studies for LYMPHOCYTIC LEUKEMIA, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for leukemia patients with other health problems
Disease control CompletedThis Phase 3 trial tested a combination of obinutuzumab and venetoclax against obinutuzumab plus chlorambucil in 445 people with untreated chronic lymphocytic leukemia (CLL) who also had other medical conditions. The goal was to see which combo worked better at delaying disease p…
Matched conditions: LYMPHOCYTIC LEUKEMIA, CHRONIC
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug combo shows promise for Tough-to-Treat blood cancers
Disease control CompletedThis study tests a drug called mosunetuzumab, given alone or with another drug (atezolizumab), in people with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia that has come back or not responded to treatment. The goal is to find the best dose and check safety and effec…
Matched conditions: LYMPHOCYTIC LEUKEMIA, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 26, 2026 16:25 UTC